Intrinsic Value

The intrinsic value of Ryman Healthcare Ltd (RH7) under the Base Case is 0.8673 EUR per share. Compared with the current market price of 0.8705 EUR, the stock appears Fairly Valued .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

RH7 Intrinsic Value
€0.8673
Fairly Valued
Intrinsic Value
Price €0.8705
Alert me when RH7 is below its intrinsic value
Today €0.6938 · 20.3% below the current price

RH7 is valued in line with its history. Trading close to its estimated value has been typical over the past 5 years.

Alternatives to RH7

Fundamental Analysis

What Ryman Healthcare Does

Health Care

Ryman Healthcare builds, owns, and runs retirement villages and aged-care homes for older adults, mainly in New Zealand and Australia. It offers independent living units, serviced apartments, and care beds, so residents can move from lighter support to more intensive care within the same community as their needs change.

Headquarters
New Zealand NZ
Employees
7 800
IPO date
Jun 25, 1999
Read the full company overview
View Company Overview

Ryman Healthcare has no economic moat

No Moat Narrow Wide

Ryman Healthcare Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue RH7 Research

Decided on Ryman Healthcare? Get an email when RH7 reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one RH7 stock?

The intrinsic value for Ryman Healthcare Ltd (RH7) under the Base Case is 0.8673 EUR.

Is RH7 stock undervalued or overvalued?

Compared with the current market price of 0.8705 EUR, the stock appears Fairly Valued .

How reliable are our estimates? See how past valuations played out
Back to Top